These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38634150)

  • 1. Monophosphoryl Lipid A-Rhamnose Conjugates as a New Class of Vaccine Adjuvants.
    Rohokale R; Guo J; Guo Z
    J Med Chem; 2024 May; 67(9):7458-7469. PubMed ID: 38634150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monophosphoryl lipid A as a co-adjuvant in methicillin-resistant Staphylococcus aureus vaccine development: improvement of immune responses in a mouse model of infection.
    Mirshekar M; Haghighat S; Mousavi Z; Abdolghaffari AH; Yazdi MH
    Immunol Res; 2024 Jun; 72(3):490-502. PubMed ID: 38383811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers.
    Zhou Z; Mondal M; Liao G; Guo Z
    Org Biomol Chem; 2014 May; 12(20):3238-45. PubMed ID: 24728423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Immunological Comparison of Differently Linked Lipoarabinomannan Oligosaccharide-Monophosphoryl Lipid A Conjugates as Antituberculosis Vaccines.
    Wang L; Feng S; Wang S; Li H; Guo Z; Gu G
    J Org Chem; 2017 Dec; 82(23):12085-12096. PubMed ID: 29112822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.
    Patil HP; Murugappan S; ter Veer W; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
    J Control Release; 2014 Jan; 174():51-62. PubMed ID: 24269505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
    Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
    BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.
    Quintilio W; Kubrusly FS; Iourtov D; Miyaki C; Sakauchi MA; Lúcio F; Dias Sde C; Takata CS; Miyaji EN; Higashi HG; Leite LC; Raw I
    Vaccine; 2009 Jun; 27(31):4219-24. PubMed ID: 19393709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy.
    Kuai R; Sun X; Yuan W; Ochyl LJ; Xu Y; Hassani Najafabadi A; Scheetz L; Yu MZ; Balwani I; Schwendeman A; Moon JJ
    J Control Release; 2018 Jul; 282():131-139. PubMed ID: 29702142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV.
    Poteet E; Lewis P; Li F; Zhang S; Gu J; Chen C; Ho SO; Do T; Chiang S; Fujii G; Yao Q
    PLoS One; 2015; 10(8):e0136862. PubMed ID: 26312747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
    Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
    mBio; 2017 May; 8(3):. PubMed ID: 28487429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime-protein boost HIV-1 vaccine.
    Pouliot K; Buglione-Corbett R; Marty-Roix R; Montminy-Paquette S; West K; Wang S; Lu S; Lien E
    Vaccine; 2014 Sep; 32(39):5049-56. PubMed ID: 25045815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic engineering of Escherichia coli to produce a monophosphoryl lipid A adjuvant.
    Ji Y; An J; Hwang D; Ha DH; Lim SM; Lee C; Zhao J; Song HK; Yang EG; Zhou P; Chung HS
    Metab Eng; 2020 Jan; 57():193-202. PubMed ID: 31786244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.
    Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A
    Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.
    Rostamian M; Niknam HM
    Mol Immunol; 2017 Nov; 91():202-208. PubMed ID: 28963929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction.
    Zhao Z; Harris B; Hu Y; Harmon T; Pentel PR; Ehrich M; Zhang C
    Biomaterials; 2018 Feb; 155():165-175. PubMed ID: 29179132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells.
    Coelho-Dos-Reis JG; Huang J; Tsao T; Pereira FV; Funakoshi R; Nakajima H; Sugiyama H; Tsuji M
    Clin Immunol; 2016 Jul; 168():6-15. PubMed ID: 27132023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.
    Bershteyn A; Hanson MC; Crespo MP; Moon JJ; Li AV; Suh H; Irvine DJ
    J Control Release; 2012 Feb; 157(3):354-65. PubMed ID: 21820024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
    Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC
    Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a single-molecule L-rhamnose-containing three-component vaccine and evaluation of antigenicity in the presence of anti-L-rhamnose antibodies.
    Sarkar S; Lombardo SA; Herner DN; Talan RS; Wall KA; Sucheck SJ
    J Am Chem Soc; 2010 Dec; 132(48):17236-46. PubMed ID: 21080675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of GM2-Monophosphoryl Lipid A Conjugate as a Fully Synthetic Self-Adjuvant Cancer Vaccine.
    Zhou Z; Mandal SS; Liao G; Guo J; Guo Z
    Sci Rep; 2017 Sep; 7(1):11403. PubMed ID: 28900154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.